Studienbeschreibung

NeuroMET2 - Metrologie und Innovation zur Früherkennung und genauen Stratifizierung von Patienten mit neurodegenerativen Erkrankungen

NeuroMET2

This project will metrologically address the challenges associated with diagnosis of AD by building upon the results of the preceding EMPIR 15HLT04 NeuroMET project and its unique patient cohort. The most promising NeuroMET minimally invasive methods for early diagnosis of AD will be advanced through longitudinal studies and transfered into clinical settings. The project will also lead to the development of novel approaches and reference measurement procedures that will address the current measurement challenges for early NDD diagnostics and therapies.

Untersuchte Krankheit, Gesundheitsproblem

• F00 - Demenz bei Alzheimer-Krankheit

Charakteristika

Nicht-interventionell

Nicht zutreffend